[Cardiological follow-up in patients with Fabry disease].
Pieruzzi
Federico
F
Dipartimento di Medicina Clinica e Prevenzione, Università degli Studi di Milano-Bicocca, Monza. federico.pieruzzi@unimib.it
Pieroni
Maurizio
M
Chimenti
Cristina
C
Frustaci
Andrea
A
Sarais
Cristiano
C
Cecchi
Franco
F
D000328:Adult; D000465:Algorithms; D001706:Biopsy; D018660:Blood Pressure Monitoring, Ambulatory; D009202:Cardiomyopathies / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000209:etiology; D003937:Diagnosis, Differential; D018450:Disease Progression; D042241:Early Diagnosis; D004452:Echocardiography; D004562:Electrocardiography; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D012720:Severity of Illness Index; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000209:etiology; D000519:alpha-Galactosidase / Q000008:administration & dosage
D000519:alpha-Galactosidase
Il follow-up cardiologico nel paziente con malattia di Fabry.